Erythrocyte galactose epimerase deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:308473OMIM:230350E74.2
Who is this for?
Show terms as
1FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Erythrocyte galactose epimerase deficiency, also known as red blood cell UDP-galactose-4-epimerase deficiency or peripheral epimerase deficiency, is a rare inherited metabolic condition that affects how the body processes the sugar galactose. Galactose is found mainly in milk and dairy products. In this condition, the enzyme called UDP-galactose-4-epimerase (GALE) does not work properly in red blood cells (and sometimes in white blood cells). This enzyme is needed to convert one form of galactose into another so the body can use or dispose of it properly. The peripheral (erythrocyte-only) form is generally considered the mildest type of galactose epimerase deficiency. Many people with this form have no symptoms at all and are discovered only through newborn screening, which may show elevated galactose levels in the blood. Because the enzyme deficiency is limited to blood cells and does not significantly affect the liver, brain, or other organs, most individuals remain healthy throughout life. However, it is important to distinguish this mild peripheral form from the more severe generalized or intermediate forms of epimerase deficiency, which can cause serious problems including liver disease, developmental delays, and cataracts. Proper diagnostic workup is essential to confirm which form a person has. In most cases of the erythrocyte-limited form, no treatment is needed, though some doctors may recommend monitoring galactose intake as a precaution. Regular follow-up with a metabolic specialist is advised, especially in infancy, to ensure the condition remains benign.

Also known as:

Key symptoms:

Elevated galactose levels found on newborn screeningUsually no noticeable symptomsMildly abnormal blood test results for galactose metabolismIn rare cases, mild jaundice in the newborn periodNo liver or brain problems in the peripheral form

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

1 available

Normocarb HF

bicarbonate infusate· Dialysis Solutions, Inc.

Use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace water and to correct electrolytes and acid-base imbalances

No actively recruiting trials found for Erythrocyte galactose epimerase deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Erythrocyte galactose epimerase deficiency community →

No specialists are currently listed for Erythrocyte galactose epimerase deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Erythrocyte galactose epimerase deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Erythrocyte galactose epimerase deficiencyForum →

No community posts yet. Be the first to share your experience with Erythrocyte galactose epimerase deficiency.

Start the conversation →

Latest news about Erythrocyte galactose epimerase deficiency

No recent news articles for Erythrocyte galactose epimerase deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Has testing confirmed that my child has the mild peripheral form and not the more severe generalized form of epimerase deficiency?,Does my child need any dietary restrictions, and if so, for how long?,How often should we follow up with a metabolic specialist?,Should other family members be tested for carrier status?,Are there any long-term health risks I should watch for?,Will this condition affect my child's growth, development, or learning?,Should we get genetic counseling before planning future pregnancies?

Common questions about Erythrocyte galactose epimerase deficiency

What is Erythrocyte galactose epimerase deficiency?

Erythrocyte galactose epimerase deficiency, also known as red blood cell UDP-galactose-4-epimerase deficiency or peripheral epimerase deficiency, is a rare inherited metabolic condition that affects how the body processes the sugar galactose. Galactose is found mainly in milk and dairy products. In this condition, the enzyme called UDP-galactose-4-epimerase (GALE) does not work properly in red blood cells (and sometimes in white blood cells). This enzyme is needed to convert one form of galactose into another so the body can use or dispose of it properly. The peripheral (erythrocyte-only) for

How is Erythrocyte galactose epimerase deficiency inherited?

Erythrocyte galactose epimerase deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Erythrocyte galactose epimerase deficiency typically begin?

Typical onset of Erythrocyte galactose epimerase deficiency is neonatal. Age of onset can vary across affected individuals.

What treatment and support options exist for Erythrocyte galactose epimerase deficiency?

1 patient support program are currently tracked on UniteRare for Erythrocyte galactose epimerase deficiency. See the treatments and support programs sections for copay assistance, eligibility, and contact details.